Mei Pharma

Mei Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

MEI Pharma is a San Diego-based clinical-stage pharmaceutical company committed to the development and commercialization of novel, best-in-class, cancer therapies intended to improve outcomes for patients. Our approach is to fully understand and leverage the mechanisms and properties of our drug candidates to optimize the balance between efficacy and tolerability to best meet the needs of patients with cancer. Each of our pipeline candidates has a unique mechanism of action that can target pathways involved in driving various hematological malignancies and/or solid tumors. Zandelisib (formerly called ME-401) is in multiple ongoing clinical trials evaluating patients with B-cell malignancies intended to support marketing approvals with the FDA and other regulatory authorities globally. Voruciclib, a potent inhibitor of CDK9, is a clinical stage drug candidate being explored in combination with standard therapies for the treatment of hematologic malignances and solid tumors. ME-344, a mitochondrial inhibitor, is a clinical stage drug candidate being evaluated for the treatment of solid tumors. We are committed to pursuing our company mission in a manner that upholds our workplace values of dedication, shared commitment, personal accountability, mutual trust and fiscal discipline. Interested in joining our team of friendly, dedicated, experienced and collaborative professionals? Visit meipharma.com/careers for more details.

Company Details

Employees
115
Founded
-
Address
11455 El Camino Real,
Phone
858-792-6300
Email
me****@****rma.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
San Diego, CA
Looking for a particular Mei Pharma employee's phone or email?

Mei Pharma Questions

News

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange Business Wire

MEI Pharma Invests in Litecoin as Primary Treasury Asset - San Diego Business Journal

MEI Pharma Invests in Litecoin as Primary Treasury Asset San Diego Business Journal

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position - Yahoo Finance

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position Yahoo Finance

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising - Business Wire

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising Business Wire

MEI Pharma Reports Fiscal Year 2021 Results and Operational Highlights - PR Newswire

MEI Pharma Reports Fiscal Year 2021 Results and Operational Highlights PR Newswire

MEI Pharma sheds biotech woes to rebrand as crypto company - Fierce Biotech

MEI Pharma sheds biotech woes to rebrand as crypto company Fierce Biotech

Voruciclib Plus Venetoclax Shows Early Activity, Tolerability in Relapsed/Refractory AML - OncLive

Voruciclib Plus Venetoclax Shows Early Activity, Tolerability in Relapsed/Refractory AML OncLive

MEI Pharma to Present at Two Healthcare Conferences - PR Newswire

MEI Pharma to Present at Two Healthcare Conferences PR Newswire

MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange - Yahoo Finance

MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange Yahoo Finance

MEI Pharma, after failed Infinity merger last year, to evaluate strategic alternatives - Fierce Biotech

MEI Pharma, after failed Infinity merger last year, to evaluate strategic alternatives Fierce Biotech

MEI Pharma Reports First Quarter Fiscal Year 2021 Results and Operational Highlights - PR Newswire

MEI Pharma Reports First Quarter Fiscal Year 2021 Results and Operational Highlights PR Newswire

MEI Pharma Chooses Not Bitcoin, Not Ethereum, But Litecoin As Treasury Asset - Yahoo Finance

MEI Pharma Chooses Not Bitcoin, Not Ethereum, But Litecoin As Treasury Asset Yahoo Finance

MEI Pharma Announces $75 Million Private Placement - PR Newswire

MEI Pharma Announces $75 Million Private Placement PR Newswire

MEI Pharma Announces 1-for-20 Reverse Stock Split - Business Wire

MEI Pharma Announces 1-for-20 Reverse Stock Split Business Wire

MEI Pharma Announces Proposed Public Offering of Common Stock - PR Newswire

MEI Pharma Announces Proposed Public Offering of Common Stock PR Newswire

MEI Pharma to Present at Two Upcoming Investor Conferences - PR Newswire

MEI Pharma to Present at Two Upcoming Investor Conferences PR Newswire

Infinity Pharmaceuticals Reports Full Year 2022 Financial Results - Business Wire

Infinity Pharmaceuticals Reports Full Year 2022 Financial Results Business Wire

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP") - PR Newswire

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP") PR Newswire

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’ - Business Wire

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’ Business Wire

MEI Pharma buys $100 million of Litecoin as treasury asset, with Charlie Lee and GSR as lead investors - theblock.co

MEI Pharma buys $100 million of Litecoin as treasury asset, with Charlie Lee and GSR as lead investors theblock.co

MEI Pharma to Present at Needham Healthcare Conference - PR Newswire

MEI Pharma to Present at Needham Healthcare Conference PR Newswire

Nasdaq-listed MEI Pharma launches $100M Litecoin treasury plan, stock rockets 50% - Crypto Briefing

Nasdaq-listed MEI Pharma launches $100M Litecoin treasury plan, stock rockets 50% Crypto Briefing

MEI Pharma To Present At Cowen And Co. Conference; Webcast At 10:40 AM ET - RTTNews

MEI Pharma To Present At Cowen And Co. Conference; Webcast At 10:40 AM ET RTTNews

MEI Pharma announces executive departures and strategic shifts - Investing.com

MEI Pharma announces executive departures and strategic shifts Investing.com

MEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officer - MarketScreener

MEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officer MarketScreener

MEI Pharma Bets $100M on Litecoin Treasury - Stocktwits

MEI Pharma Bets $100M on Litecoin Treasury Stocktwits

The Infinity-MEI merger saga finally ends in shareholders sinking the deal - Fierce Biotech

The Infinity-MEI merger saga finally ends in shareholders sinking the deal Fierce Biotech

Top Mei Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant